Dharmica is the winner of the “InStyle (magazine) Women of Style Awards” in the Science category, May 2017. The judges included Nicole Kidman, Deborra-lee Furness, Gillian Armstrong, Layne Beachley and Colette Dinnigan. Read more..
Dr Dharmica Mistry announced as 1 of 3 nominee finalists in the Science category, for the “InStyle Women of Style Awards” by InStyle Magazine Australia. (April) issue of InStyle magazine. Announcement of the winner will be in May at an awards ceremony.
Dr Dharmica Mistry is one of the Australian scientists behind a groundbreaking discovery that will make it possible to detect breast cancer through a blood test. It was pure chance that led Dr Dharmica Mistry to make the discovery that could change the lives of millions of people affected by breast cancer. Since that day, […]
Dharmica Mistry has good news for women who dislike having their breasts pushed and pinched into position for a mammogram nearly as much as they fear breast cancer itself. If her Breast Cancer Associated Lipids (BCAL) blood test passes clinical trials in 2017, they might not have to undergo that ordeal any more. Read more..
In the latest instalment of the 40 under 40 series, Morgans Adviser Chris Titley spoke with Dharmica Mistry PhD, Chief Scientist of BCAL Diagnostics. Dharmica discusses her background and the personal experiences which led to the founding of BCAL. This insightful and inspiring interview covers the challenges in breast cancer screening, the way forward for technology […]
Young shire scientist’s discovery of simple breast cancer blood screening test set to undergo clinical trials
While 2016 was a big year for Dharmica Mistry, a young scientist from Sydney’s south, the next 12 months will be even more important. Dr Mistry’s discovery that a simple blood test could be used to screen women for breast cancer led to her being named the 2016 NSW Young Woman of the Year. Her work […]
In the media , thanks to our Chief Scientist Dr. Dharmica Mistry, 2016 was a very strong year for publicity with Dharmica featuring (click on the image to go to the article): In the Australian Financial Review (AFR) in February In a in depth interview with Fran Kelly on ABC Radio National also in March In the October […]
Independent Publication BCAL Dx’s approach to testing for breast cancer has been further independently validated with the publication of a paper by a group at Rush Medical University in Chicago. Their paper, highlighted in our July Newsletter, gave further strong support to BCAL Dx unique approach. The company is well advanced in collaborative discussions with […]
In August 2016 BCAL Dx welcomed Carl Stubbings to head the company’s commercialisation efforts. Carl has considerable experience in the commercialisation of diagnostic products with a particular focus on the USA. Carl’s bio is available on the BCAL Dx website. Regulatory Strategy and Market Roll Out BCAL Dx is pleased to report that the company […]
BCAL Dx successfully secured patents in Australia and Japan. BCAL Dx has an exclusive global license to the blood testing technology from the University of Louisville (UoL) in the US. We have been working with the UoL over the last three years to prosecute the patents. In May 2016, the Japanese patent was granted and […]